52471-10-0

Upstream product

• 6125-31-1 2-chloro-N-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]acetamide 
• 1147550-11-5 ammonium thiocyanate 
• 2103-99-3 4-(4-chlorophenyl)-2-thiazolamine 
• 6635-76-3 N-(4-p-Chlorophenyl-2-thiazolyl)thiourea 
• 79-11-8 chloroacetic acid 

Downstream Products

• 52414-01-4 2-{[4-(4-chlorophenyl)-1,3-thiazol-2-yl]imino}-5-(4-methoxybenzylidene)-1,3-thiazolidin-4-one 
• 52414-03-6 2-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-5-(2-nitro-benzylidene)-thiazol-4-one 
• 52414-15-0 5-bromo-5-[bromo-(2-chloro-phenyl)-methyl]-2-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-thiazol-4-one 
• 52551-26-5 5-bromo-5-(bromo-phenyl-methyl)-2-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-thiazol-4-one 
• 1133387-77-5 C₁₉H₁₁Cl₂N₃OS₂ 
• 52471-14-4 5-benzylidene-2-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-thiazol-4-one 
• 52414-02-5 2-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-5-(4-nitro-benzylidene)-thiazol-4-one 
• 52414-04-7 5-(2-chloro-benzylidene)-2-[4-(4-chloro-phenyl)-thiazol-2-ylamino]-thiazol-4-one 

Relevant academic research and scientific papers

Synthesis and biological evaluation of novel 2-heteroarylimino-1,3-thiazolidin-4-ones as potential anti-tumor agents

A series of 35 heteroarylimino-1,3-thiazolidinones with three sites of functionalization were synthesized and their antiproliferative properties were studied. The in vitro screening by MTT assay was performed against five cancer cell lines (human colon cancer cell lines HT29, HCT116 and SW620 and breast cancer cell lines MCF7 and MDA-MB-231). It was observed that N3-substituted thiazolidinones had moderate activities whereas 5-benzylidene thiazolidinones showed promising activities. To investigate the mechanism of action, detailed biological studies of six selected compounds (those presenting the lower mitotic index) were carried out on the human colon cancer HT29 cell line. Cell cycle assay revealed that those compounds induced cell accumulation in G2/M and in subG0/G1 phases of cell cycle. Moreover, dissipation of mitochondria membrane potential was observed as well as redox changes in treated cells.

Synthesis and characterization of some 3-N-alkoxyphthalimido-5-arylidene-2- {[4-(4-substituted phenyl)-1,3-thiazol-2-yl]imino}-1,3-thiazolidin-4-ones

4-Chloro/methyl phenacyl bromide 1a-b reacted with thiourea to furnish 2-amino thiazole 2a-b through Hantzsch's process, which were converted to their thiazolidinone derivatives 4a-b, by the reaction of corresponding thiazolyl thiourea 3a-b with chloroace